Clinical Trial Update: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

View source ↗

Summary

This terminated clinical trial evaluated whether a chemoresponse assay correlates with progression-free survival in patients with recurrent epithelial ovarian, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Precision Therapeutics | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Status: TERMINATED